O. Saatci Et Al. , "Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer," Nature Communications , vol.14, no.1, 2023
Saatci, O. Et Al. 2023. Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer. Nature Communications , vol.14, no.1 .
Saatci, O., Cetin, M., ÜNER, M., Tokat, U. M., Chatzistamou, I., Ersan, P. G., ... Montaudon, E.(2023). Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer. Nature Communications , vol.14, no.1.
Saatci, Ozge Et Al. "Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer," Nature Communications , vol.14, no.1, 2023
Saatci, Ozge Et Al. "Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer." Nature Communications , vol.14, no.1, 2023
Saatci, O. Et Al. (2023) . "Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer." Nature Communications , vol.14, no.1.
@article{article, author={Ozge Saatci Et Al. }, title={Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer}, journal={Nature Communications}, year=2023}